YY1 and diabetes mellitus: Therefore, as described in Fig. 5, we propose a novel molecular mechanism involved in hepatic glucose metabolism by the BTG2–YY1 signaling network that may provide a better understanding to develop a novel therapeutic agent for metabolic dysfunction like diabetes.